BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8891361)

  • 1. Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group.
    Drake JM; Kestle J
    Childs Nerv Syst; 1996 Aug; 12(8):434-47. PubMed ID: 8891361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
    Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
    Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus.
    Tuli S; O'Hayon B; Drake J; Clarke M; Kestle J
    Neurosurgery; 1999 Dec; 45(6):1329-33; discussion 1333-5. PubMed ID: 10598700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF shunts 50 years on--past, present and future.
    Drake JM; Kestle JR; Tuli S
    Childs Nerv Syst; 2000 Nov; 16(10-11):800-4. PubMed ID: 11151733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory testing of hydrocephalus shunts -- conclusion of the U.K. Shunt evaluation programme.
    Czosnyka Z; Czosnyka M; Richards HK; Pickard JD
    Acta Neurochir (Wien); 2002 Jun; 144(6):525-38; discussion 538. PubMed ID: 12111485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of infantile hydrocephalus: "differential-pressure" or "flow-control" valves. A pilot study.
    Jain H; Sgouros S; Walsh AR; Hockley AD
    Childs Nerv Syst; 2000 Apr; 16(4):242-6. PubMed ID: 10855523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrodynamic properties of hydrocephalus shunts.
    Czosnyka Z; Czosnyka M; Richards H; Pickard JD
    Acta Neurochir Suppl; 1998; 71():334-9. PubMed ID: 9779223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting.
    Kehler U; Kiefer M; Eymann R; Wagner W; Tschan CA; Langer N; Rohde V; Ludwig HC; Gliemroth J; Meier U; Lemcke J; Thomale UW; Fritsch M; Krauss JK; Mirzayan MJ; Schuhmann M; Huthmann A
    Clin Neurol Neurosurg; 2015 Oct; 137():132-6. PubMed ID: 26196478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posture-related overdrainage: comparison of the performance of 10 hydrocephalus shunts in vitro.
    Czosnyka Z; Czosnyka M; Richards HK; Pickard JD
    Neurosurgery; 1998 Feb; 42(2):327-33; discussion 333-4. PubMed ID: 9482183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up data from the Shunt Design Trial.
    Kestle J; Drake J; Milner R; Sainte-Rose C; Cinalli G; Boop F; Piatt J; Haines S; Schiff S; Cochrane D; Steinbok P; MacNeil N
    Pediatr Neurosurg; 2000 Nov; 33(5):230-236. PubMed ID: 11155058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices.
    Aschoff A; Kremer P; Benesch C; Fruh K; Klank A; Kunze S
    Childs Nerv Syst; 1995 Apr; 11(4):193-202. PubMed ID: 7621479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was used.
    Hanlo PW; Cinalli G; Vandertop WP; Faber JA; Bøgeskov L; Børgesen SE; Boschert J; Chumas P; Eder H; Pople IK; Serlo W; Vitzthum E
    J Neurosurg; 2003 Jul; 99(1):52-7. PubMed ID: 12854744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
    Meling TR; Egge A; Due-Tønnessen B
    Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the siphoning effect in new shunt designs by decoupling the activation pressure and the pressure gradient across the valve.
    Mattei TA; Morris M; Nowak K; Smith D; Yee J; Goulart CR; Zborowski A; Lin JJ
    J Neurosurg Pediatr; 2013 Feb; 11(2):181-7. PubMed ID: 23215676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the distal double-slit valve system in children with hydrocephalus.
    Hahn YS
    Childs Nerv Syst; 1994 Mar; 10(2):99-103. PubMed ID: 8033170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Delta Valve: a physiologic shunt system.
    Watson DA
    Childs Nerv Syst; 1994 May; 10(4):224-30. PubMed ID: 7923231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of normal-pressure hydrocephalus: comparison of flow-regulated and differential-pressure shunt valves.
    Weiner HL; Constantini S; Cohen H; Wisoff JH
    Neurosurgery; 1995 Nov; 37(5):877-84. PubMed ID: 8559335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
    Pollack IF; Albright AL; Adelson PD
    Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjustable antisiphon shunt.
    Sood S; Canady AI; Ham SD
    Childs Nerv Syst; 1999 May; 15(5):246-9. PubMed ID: 10392496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The delta valve: how does its clinical performance compare with two other pressure differential valves without antisiphon control?
    Davis SE; Levy ML; McComb JG; Sposto R
    Pediatr Neurosurg; 2000 Aug; 33(2):58-63. PubMed ID: 11070430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.